- $12.2 BnWorld market, 2023
- $46.8 BnProjected, 2033
- 14.4%Growth a year (CAGR)
- 209Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$5.1 Bn
12.4% a year · 42% of the world -
2
China
$981 Mn
15.9% a year · 8% of the world -
3
Canada
$976 Mn
14.4% a year · 8% of the world -
4
Japan
$758 Mn
14.9% a year · 6.2% of the world -
5
Germany
$447 Mn
12.6% a year · 3.7% of the world -
6
France
$336 Mn
13.4% a year · 2.8% of the world -
7
UK
$317 Mn
12.4% a year · 2.6% of the world -
8
Brazil
$305 Mn
15.4% a year · 2.5% of the world -
9
Italy
$293 Mn
13.9% a year · 2.4% of the world -
10
Ecuador
$244 Mn
15% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)Bioinformatics by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $12.2 Bn | $46.8 Bn | 14.4% | – | 209 | Report on Bioinformatics in Global |
| North America | $6.1 Bn | $21.5 Bn | 13.4% | 50% | 53 | Report on Bioinformatics in North America |
| APAC | $2.6 Bn | $11 Bn | 15.7% | 21% | 32 | Report on Bioinformatics in APAC |
| Europe | $2.3 Bn | $8 Bn | 13.1% | 19% | 73 | Report on Bioinformatics in Europe |
| Latin America | $549 Mn | $2.3 Bn | 15.4% | 4.5% | 2 | Report on Bioinformatics in Latin America |
| Middle East | $488 Mn | $2 Bn | 15.4% | 4% | 0 | Report on Bioinformatics in Middle East |
| Africa | $183 Mn | $800 Mn | 15.9% | 1.5% | 2 | Report on Bioinformatics in Africa |
| US |
$5.1 Bn | $16.5 Bn | 12.4% | 42% | 47 | Report on Bioinformatics in US |
| China |
$981 Mn | $4.3 Bn | 15.9% | 8% | 30 | Report on Bioinformatics in China |
| Canada |
$976 Mn | $3.7 Bn | 14.4% | 8% | 7 | Report on Bioinformatics in Canada |
| Japan |
$758 Mn | $3 Bn | 14.9% | 6.2% | 0 | Report on Bioinformatics in Japan |
| Germany |
$447 Mn | $1.5 Bn | 12.6% | 3.7% | 3 | Report on Bioinformatics in Germany |
| France |
$336 Mn | $1.2 Bn | 13.4% | 2.8% | 24 | Report on Bioinformatics in France |
| UK |
$317 Mn | $1 Bn | 12.4% | 2.6% | 7 | Report on Bioinformatics in UK |
| Brazil |
$305 Mn | $1.3 Bn | 15.4% | 2.5% | 1 | Report on Bioinformatics in Brazil |
| Italy |
$293 Mn | $1.1 Bn | 13.9% | 2.4% | 34 | Report on Bioinformatics in Italy |
| Ecuador |
$244 Mn | $989 Mn | 15% | 2% | 0 | Report on Bioinformatics in Ecuador |
 Spain |
$236 Mn | $828 Mn | 13.4% | 1.9% | 7 | Report on Bioinformatics in Spain |
 India |
$222 Mn | $1.1 Bn | 17.4% | 1.8% | 0 | Report on Bioinformatics in India |
 Saudi Arabia |
$207 Mn | $907 Mn | 15.9% | 1.7% | 0 | Report on Bioinformatics in Saudi Arabia |
 Mexico |
$183 Mn | $718 Mn | 14.7% | 1.5% | 1 | Report on Bioinformatics in Mexico |
 Australia |
$146 Mn | $640 Mn | 15.9% | 1.2% | 1 | Report on Bioinformatics in Australia |
 South Africa |
$79 Mn | $339 Mn | 15.6% | 0.7% | 1 | Report on Bioinformatics in South Africa |
 UAE |
$61 Mn | $256 Mn | 15.4% | 0.5% | 0 | Report on Bioinformatics in UAE |
 Egypt |
$34 Mn | $149 Mn | 15.9% | 0.3% | 1 | Report on Bioinformatics in Egypt |
 Philippines |
$27 Mn | $108 Mn | 14.9% | 0.2% | 0 | Report on Bioinformatics in Philippines |
 Malaysia |
$20 Mn | $77 Mn | 14.6% | 0.2% | 1 | Report on Bioinformatics in Malaysia |
 Hong Kong |
$20 Mn | $82 Mn | 15.4% | 0.2% | 0 | Report on Bioinformatics in Hong Kong |
 Singapore |
$15 Mn | $59 Mn | 15% | 0.1% | 1 | Report on Bioinformatics in Singapore |
 Thailand |
$15 Mn | $58 Mn | 14.7% | 0.1% | 0 | Report on Bioinformatics in Thailand |
 Kenya |
$9 Mn | $36 Mn | 15.5% | 0.1% | 1 | Report on Bioinformatics in Kenya |
 New Zealand |
– | – | – | – | 1 | Report on Bioinformatics in New Zealand |
 Russia |
– | – | – | – | 0 | Report on Bioinformatics in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 73,053 papers since 2021
- MEG3 overexpression modulates proliferation and angiogenic signaling in oral squamous cell carcinoma: An In silico and experimental study. Journal of stomatology, oral and maxillofacial surgery, 2026
- Impact of training data on deep learning-based RNA 3D structure quality assessment. Briefings in bioinformatics, 2026
- A recall-rescue fuzzy layer over paired Z-DNA Hunter scans for fast Z-DNA detection. Briefings in bioinformatics, 2026
- The lncRNA SEPT5-GP1BB-encoded peptide ARP, upregulated by 17β-estradiol, retards H(2)O(2)-induced senescence of human umbilical vein endothelial cells by promoting autophagy. Biogerontology, 2026
- Identification and Virtual Screening of Umami Peptides in HPLC Fractions of Tauco by LC-MS/MS and Bioinformatics Tools. Journal of food science, 2026
Compare Bioinformatics side by side
Key companies in Bioinformatics
Illumina, Inc.
Thermo Fisher Scientific
Qiagen NV
Agilent Technologies
PerkinElmer
BGI Genomics
Data4Cure
Quest Diagnostics (Celera Corporation)
Bio-Rad Laboratories
Broad Institute of MIT and Harvard
Qiagen NV
Agilent Technologies
PerkinElmer
BGI Genomics
Data4Cure
Quest Diagnostics (Celera Corporation)
Bio-Rad Laboratories
Broad Institute of MIT and Harvard
Quick answers
How big is the Bioinformatics market?
The world Bioinformatics market was worth about $12.2 Bn in 2023 and is projected to reach $46.8 Bn by 2033, growing 14.4% a year (CAGR).
Which country has the largest Bioinformatics market?
The US is the largest of the 24 countries we cover, at $5.1 Bn in 2023. India grows fastest, at 17.4% a year.
How many clinical trials are running in Bioinformatics?
ClinicalTrials.gov lists 209 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Bioinformatics?
PubMed lists about 73,053 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.